Close Menu

NEW YORK (GenomeWeb) – DiaSorin Molecular said today that the US Food and Drug Administration has cleared the company's Simplexa VZV Direct assay for detecting varicella-zoster virus.

The assay is for use with cerebrospinal fluid samples and can help in diagnosing meningitis and encephalitis. It requires 50 microliters of CSF per test and can be used with DiaSorin Molecular's Liaison MDx instrument. It also complements the Cypress, California-based firm's Simplexa HSV 1 and 2 Direct assay, the company said.

To read the full story....

...and receive Daily News bulletins.

Already have a 360Dx or GenomeWeb account?
Login Now.

Don't have a 360Dx or GenomeWeb account?
Register for Free.

Apr
29
Sponsored by
Co-Diagnostics

Join Dr. Heather Fehling, Chief Scientific Officer at Clinical Reference Labs (CRL), as she provides some insights regarding the future applications of PCR testing.

May
18
Sponsored by
Bio-Rad

This webinar will present the details of a COVID-19 saliva screening program that has been implemented at more than 90 different colleges, universities, private schools, and nursing homes across New York state.